http://orcid.org/0000-0002-4081-4741
Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mira Mekhael, Helene M. Larsen, Michael B. Lauritzen, Ole Thorlacius-Ussing, Søren Laurberg, Klaus Krogh, Asbjørn M. Drewes, Peter Christensen & Therese Juul. (2023) Bowel dysfunction following pelvic organ cancer: a prospective study on the treatment effect in nurse-led late sequelae clinics. Acta Oncologica 62:1, pages 70-79.
Read now
Read now
Susanne Haas, Anette H. Mikkelsen, Camilla Kronborg, Birthe T. Oggesen, Pia Moeller Faaborg, Eva Serup-Hansen, Karen-Lise G. Spindler & Peter Christensen. (2021) Management of late adverse effects after chemoradiation for anal cancer. Acta Oncologica 60:12, pages 1688-1701.
Read now
Read now
Articles from other publishers (37)
Anouk Corbeau, Wilma D. Heemsbergen, Sander C. Kuipers, Jeremy Godart, Carien L. Creutzberg, Remi A. Nout & Stephanie M. de Boer. (2024) Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics 119:1, pages 127-142.
Crossref
Crossref
Shin Murai, Hiroaki Nozawa, Kazutaka Yamada, Yasumitsu Saiki, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Hiroyuki Matsuzaki, Yuichiro Yokoyama, Shinya Abe, Yuzo Nagai, Yuichiro Yoshioka, Takahide Shinagawa, Hirofumi Sonoda, Kenichi Sugihara, Yoichi Ajioka & Soichiro Ishihara. (2024) Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan. International Journal of Clinical Oncology.
Crossref
Crossref
Anna Axelsson, Mia Johansson, Eva Haglind, Ying Li, Per J. Nilsson & Eva Angenete. (2023) Patient reported long‐term side effects on bowel function and anal pain in anal cancer survivors – 3‐ and 6‐year results from the Swedish national ANCA study. Colorectal Disease 26:1, pages 54-62.
Crossref
Crossref
Kurian Joseph, Mustafa Al Balushi, Sunita Ghosh, Trevor Stenson, Aswin Abraham, Arun Elangovan, Heather Warkentin, Kim Paulson, Keith Tankel, Nawaid Usmani, Diane Severin, Dan Schiller, Clarence Wong, Karen Mulder, Corinne Doll, Karen King & Tirath Nijjar. (2023) Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial. International Journal of Radiation Oncology*Biology*Physics 117:2, pages 434-445.
Crossref
Crossref
Birthe Thing Oggesen, Marie Louise Sjødin Hamberg & Jacob Rosenberg. (2023) Practical management algorithms for late complications after colorectal and anal cancer—Basic treatment of late complications. Medicine Advances 1:3, pages 260-269.
Crossref
Crossref
Margherita Rotondi, Giuseppe Facondo, Stefano Mossa, Gianluca Vullo, Ilaria Angelicone, Maurizio Valeriani & Mattia Falchetto Osti. (2023) Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy. International Journal of Colorectal Disease 38:1.
Crossref
Crossref
Marianna Alessandra Gerardi, Maria Alessia Zerella, Luca Bergamaschi, Annamaria Ferrari, Simona Arculeo, Vincenzo Bagnardi, Samuele Frassoni, Wanda Petz, Cristiana Fodor, Francesca Emiro, Federica Cattani, Maria Cristina Leonardi, Maria Giulia Zampino & Barbara Alicja Jereczek-Fossa. (2023) Intensity-modulated radiotherapy and cisplatin-based chemotherapy for anal cancer: long-term outcomes at a single institution. International Journal of Colorectal Disease 38:1.
Crossref
Crossref
Sule Karabulut GUL, Huseyin Tepetam, Ferah Yildiz, Ilhami Er, Didem Colpan Oksuz, Murtaza Parvizi, Ayse Sevgi Ozden, Zumre Arican Alicikus, Sezin Yuce Sari, Omar Alomari & Ilknur Bilkay Gorken. (2023) Revisiting the Radical Radiotherapy-Radiochemotherapy Results in Anal Canal Cancers: (TROD Gastrointestinal Group Study 02-005). Clinical Colorectal Cancer.
Crossref
Crossref
H Ruymbeke, J Geldof, D De Looze, M.A. Denis, H De Schepper, P Dewint, I Gijsen, M Surmont, J Wyndaele & P Roelandt. (2023) Secondary anal fissures: a pain in the a**. Acta Gastro Enterologica Belgica 86:1, pages 58-67.
Crossref
Crossref
Karen J. Neelis, Django M. Kip, Frank M. Speetjens & Yvette M. van der Linden. (2022) Treatment results for patients with squamous-cell carcinoma of the anus, a single institution retrospective analysis. Radiation Oncology 17:1.
Crossref
Crossref
Christina Sauter, Jan C. Peeken, Kai Borm, Christian D. Diehl, Stefan Münch, Stephanie E. Combs & Hendrik Dapper. (2022) Influence of radiation treatment technique (IMRT vs. 3D-RT) on acute toxicity and prognostic factors for survival for anal cancer. Scientific Reports 12:1.
Crossref
Crossref
Fatima Qays Ismail, Stina Öberg, Birthe Thing Oggesen, Ida Hageman & Jacob Rosenberg. (2022) Patient-Reported Outcome Measures to Screen for Depressive Symptoms and Depression in Patients with Colorectal and Anal Cancer: a Systematic Scoping Review. SN Comprehensive Clinical Medicine 4:1.
Crossref
Crossref
Huiwen Lu, Yimeng Sun, Zirui Zhu, Junqiao Yao, Huimian Xu, Rui Huang & Baojun Huang. (2022) Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology 29:11, pages 6962-6975.
Crossref
Crossref
Kelsey L. Corrigan, Michael K. Rooney, Brian De, Ethan D. Ludmir, Prajnan Das, Grace L. Smith, Cullen Taniguchi, Bruce D. Minsky, Eugene J. Koay, Albert Koong, Van K. Morris, Craig A. Messick, Graciela Nogueras-Gonzalez & Emma B. Holliday. (2022) Patient-Reported Sexual Function in Long-Term Survivors of Anal Cancer Treated With Definitive Intensity Modulated Radiation Therapy and Concurrent Chemotherapy. Practical Radiation Oncology 12:5, pages e397-e405.
Crossref
Crossref
Brian De, Kelsey L. Corrigan, Michael K. Rooney, Ethan B. Ludmir, Prajnan Das, Grace L. Smith, Cullen M. Taniguchi, Bruce D. Minsky, Eugene J. Koay, Albert Koong, Van K. Morris, Craig A. Messick, Y. Nancy You, George J. Chang, O. Lenaine Westney, Graciela M. Nogueras Gonzalez & Emma B. Holliday. (2022) Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy. International Journal of Radiation Oncology*Biology*Physics 114:1, pages 78-88.
Crossref
Crossref
Kelsey L. Corrigan, Brian De, Michael K. Rooney, Ethan B. Ludmir, Prajnan Das, Grace L. Smith, Cullen M. Taniguchi, Bruce D. Minsky, Eugene J. Koay, Albert C. Koong & Emma B. Holliday. (2022) Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis. Advances in Radiation Oncology 7:4, pages 100986.
Crossref
Crossref
Grete K. Velure, Bernd Müller & May Aa. Hauken. (2022) Symptom burden and health-related quality of life six months after hyperbaric oxygen therapy in cancer survivors with pelvic radiation injuries. Supportive Care in Cancer 30:7, pages 5703-5711.
Crossref
Crossref
Anna Axelsson, Mia Johansson, David Bock, Eva Haglind, Hanna de la Croix, Per J. Nilsson & Eva Angenete. (2022) Patient-reported QoL in anal cancer survivors 3 and 6 years after treatment—results from the Swedish national ANCA study. Supportive Care in Cancer 30:5, pages 4169-4178.
Crossref
Crossref
Christina Sauter, Jan C. Peeken, Kai Borm, Christian Diehl, Stefan Münch, Stephanie E. Combs & Hendrik Dapper. (2022) Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancer. Scientific Reports 12:1.
Crossref
Crossref
WeiWei Xiao, Yan Yuan, SuiHai Wang, Zhidong Liao, PeiQiang Cai, BaoQing Chen, Rong Zhang, Fang Wang, ZhiFan Zeng & YuanHong Gao. (2022) Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis. Frontiers in Immunology 12.
Crossref
Crossref
M.P. Nilsson, A. Gunnlaugsson, A. Johnsson & J. Scherman. (2022) Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer. Clinical Oncology 34:1, pages e35-e44.
Crossref
Crossref
Guangxia Chen, Yi Han, Haihan Zhang, Wenling Tu & Shuyu Zhang. (2021) Radiotherapy-Induced Digestive Injury: Diagnosis, Treatment and Mechanisms. Frontiers in Oncology 11.
Crossref
Crossref
Julius Pacevicius, Vidas Petrauskas, Lukas Pilipavicius & Audrius Dulskas. (2021) Local Excision ± Chemoradiotherapy vs. Total Mesorectal Excision for Early Rectal Cancer: Case-Matched Analysis of Long-Term Results. Frontiers in Surgery 8.
Crossref
Crossref
G. Camprodon & F. Huguet. (2021) Unrecognized digestive toxicities of radiation therapy. Cancer/Radiothérapie 25:6-7, pages 723-728.
Crossref
Crossref
Paul Sargos, Mame Daro Faye, Manon Bacci, Stéphane Supiot, Igor Latorzeff, David Azria, Tamim M. Niazi, Te Vuong, Véronique Vendrely & Renaud de Crevoisier. (2021) Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review. Frontiers in Oncology 11.
Crossref
Crossref
Natalie Schindler & Irenäus A. Adamietz. (2021) Behandlung des AnalkarzinomsTreatment of anal cancer. Der Onkologe 27:6, pages 615-624.
Crossref
Crossref
Felix Aigner, Robert Siegel, Ricardo N. Werner, Stefan Esser, Mark Oette, Gerhard Weyandt, Volker Kahlke, Adal Saeed, Matthias Turina, Franz A. Mosthaf, Stefan Dresel, Steffen Simon, Gerald Niedobitek, Stephan Koswig, Volker Budach, Jan Schmielau, Hans-Rudolf Raab, Gerhard Faber, Bianca Senf, Claus Rödel, E. Fokas, Rolf Mahlberg, Maria Steingräber, Johannes Weßling, Ulrike Wieland, Alois Fürst, Petra Lugger, Franz‑Josef Prott, Irmgard Kronberger, Stephan Baumeler, Christine Maurus, Erich Grohmann, Matthew Gaskins, Gabriela L. Avila Valle & Martin Dittmann. (2021) S3-Leitlinie AnalkarzinomS3 guideline anal carcinoma. coloproctology 43:3, pages 150-216.
Crossref
Crossref
Eric Miller & Jose Bazan. (2021) De-Escalation of Therapy for Patients with Early-Stage Squamous Cell Carcinoma of the Anus. Cancers 13:9, pages 2099.
Crossref
Crossref
Camilla J.S. Kronborg, Peter Christensen, Bodil G. Pedersen & Karen-Lise G. Spindler. (2021) Anorectal function and radiation dose to pelvic floor muscles after primary treatment for anal cancer. Radiotherapy and Oncology 157, pages 141-146.
Crossref
Crossref
Eric Miller, Ansel Nalin, Dayssy Diaz Pardo, Andrea Arnett, Laith Abushahin, Syed Husain, Ning Jin, Terence Williams & Jose Bazan. (2020) Stage I Squamous Cell Carcinoma of the Anus: Is Radiation Therapy Alone Sufficient Treatment?. Cancers 12:11, pages 3248.
Crossref
Crossref
Ahmed N.A.M. Afifi, Maciej Powerski, Dörthe Jechorek, Thomas B. Brunner, Jochen Weigt & Marino Venerito. (2020) Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options. Best Practice & Research Clinical Gastroenterology 48-49, pages 101711.
Crossref
Crossref
Diane Mege, Guillaume Meurette, Bertrand Trilling, Paul-Antoine Lehur, Vincent Wyart, Valérie Bridoux, Henri Damon, Elsa Lambrescak, Jean-Luc Faucheron, Igor Sielezneff, François Mion, Isabelle Etienney, Anne-Marie Leroi, Laurent Siproudhis & Charlène Brochard. (2020) Efficacy and safety of sacral nerve modulation for faecal incontinence after pelvic radiotherapy. Radiotherapy and Oncology 146, pages 167-171.
Crossref
Crossref
Maïlys de Meric de Bellefon, Claire Lemanski, Florence Castan, Emmanuelle Samalin, Thibault Mazard, Alexis Lenglet, Sylvain Demontoy, Olivier Riou, Carmen Llacer-Moscardo, Pascal Fenoglietto, Norbert Aillères, Simon Thezenas, Charles Debrigode, Sabine Vieillot, Sophie Gourgou & David Azria. (2020) Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure. Radiotherapy and Oncology 144, pages 141-147.
Crossref
Crossref
Nilufer Kılıc Durankus, Duygu Sezen, Ugur Selek & Yasemin Bolukbasi. 2020. Prevention and Management of Acute and Late Toxicities in Radiation Oncology. Prevention and Management of Acute and Late Toxicities in Radiation Oncology
231
266
.
Daniel Martin, Franz Rödel, Panagiotis Balermpas, Ria Winkelmann, Emmanouil Fokas & Claus Rödel. (2019) C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy. Frontiers in Oncology 9.
Crossref
Crossref
Cathy Eng, Craig Messick & Rob Glynne-Jones. (2019) The Management and Prevention of Anal Squamous Cell Carcinoma. American Society of Clinical Oncology Educational Book:39, pages 216-225.
Crossref
Crossref
D. Martin, C. Rödel & E. Fokas. (2019) Chemoradiotherapy for anal cancer: are we as good as we think?Radiochemotherapie für das Analkarzinom: Sind wir so gut, wie wir denken?. Strahlentherapie und Onkologie 195:5, pages 369-373.
Crossref
Crossref